13.04 Improving the efficacy of TCRtg T cell therapy for solid tumors with mRNA-based vaccination

• J Lutz,
• J Ruotsalainen,
• J Krueger,
• R Mülfarth,
• R Heidenreich

Affiliations

J Lutz

1Department of medicine, University medical centre of the Johannes Gutenberg University, Mainz, Germany

J Ruotsalainen

2Finland

J Krueger

CurVac SE, Tübingen, Germany

R Mülfarth

CurVac SE, Tübingen, Germany

R Heidenreich

CurVac SE, Tübingen, Germany